Taglich Brothers Releases Updated Coverage on Cosmos Health: Projects Positive EPS for 2025 and Sets $3 Price Target, Nearly 300% Above Current Share Price

November 26, 2024 9:30 AM

CHICAGO, IL / ACCESSWIRE / November 26, 2024 / Cosmos Health Inc. ("Cosmos Health" or the "Company'') (NASDAQ:COSM), a diversified, vertically integrated global healthcare group engaged in innovative R&D, owner of proprietary pharmaceutical and nutraceutical brands, manufacturer and distributor of healthcare products, and operator of a telehealth platform, announced today that, on November 25, 2024, Taglich Brothers, Inc. ("Taglich") published...

Read more

Revolutionizing Healthcare: Lexaria Highlights Expanding Therapeutic Benefits of GLP-1 Drugs

November 26, 2024 9:20 AM

KELOWNA, BC / ACCESSWIRE / November 26, 2024 / Lexaria Bioscience Corp. (NASDAQ:LEXX)(NASDAQ:LEXXW) (the "Company" or "Lexaria"), a global innovator in drug delivery platforms, provides the following strategic update.Today's GLP-1 drug market consists primarily of semaglutide (Wegovy®, Ozempic®, and Rybelsus®), owned by Novo Nordisk®; and tirzepatide (Zepbound®, Mounjaro®), owned by Eli Lilly™. All five of those drug brands, with the exception...

Read more

Local, Female-Owned, Raleigh Business Shines on National Reality Show The Blox

November 26, 2024 9:15 AM

The business world is buzzing as Georgia Homsany, the founder of Daily Dose Wellness, steps into the limelight on the acclaimed reality series, The Blox, to claim the coveted title of the greatest start-up company in the nation. This ultimate entrepreneurial journey follows her as she tackles a series of high-stakes business challenges, offering viewers an unprecedented look at the trials, triumphs, and transformation of an emerging...

Read more

Pathways Health Partners Delivers Standout Performance in Florida's ACO REACH Model, Redefining Standards in Value-Based Care

November 26, 2024 9:15 AM

Pathways Health Partners has emerged as one of Florida's top-performing ACOs under the ACO REACH Model for 2023, establishing itself as a formidable player in value-based care. Through a thoughtful mix of cost-saving strategies and patient-centered care, the organization reported $25 million in Gross Savings and an impressive 10.23% Gross Savings Rate. Serving over 15,000 Medicare beneficiaries across the state, Pathways Health Partners'...

Read more

Proving the Concept: Aptevo Technology, Pipeline, to Exemplify the Speed and Power of Modular Biotherapeutics at Presentation

November 26, 2024 8:35 AM

Aptevo Therapeutics ("Aptevo") (NASDAQ:APVO), a clinical-stage biotechnology company focused on developing novel immune-oncology therapeutics based on its proprietary ADAPTIR™ and ADAPTIR-FLEX™ platform technologies, todayannounced that Peter Pavlik, PhD, Senior Director of Protein Engineering, will chair a "Bi and Multispecific Biologics" session and present a talk titled "Modular Multispecific Biotherapeutics: Rapid Therapeutic Design with the...

Read more

Parker Family Health Center Celebrates Expansion

November 26, 2024 8:30 AM

NORTHAMPTON, MA / ACCESSWIRE / November 26, 2024 / Quest Diagnostics The Parker Family Health Center (PFHC), which provides free medical care for uninsured or underinsured residents of Monmouth County, NJ, recently celebrated its newly expanded and renovated facility with a ribbon cutting ceremony, with members of Quest's team in attendance to show support.Based in Red Bank, NJ, PFHC receives no-cost lab testing from Quest Diagnostics as part of...

Read more

Dr. Alisa Yamasaki Featured in Princeton Health Magazine Discussing Advanced Treatments for Bell's Palsy to Restore Facial Symmetry

November 26, 2024 8:00 AM

Dr. Alisa Yamasaki, a board-certified facial plastic and reconstructive surgeon, is featured in Princeton Health Magazine, where she discusses various facial reanimation techniques for treating Bell's Palsy. This interview sheds light on the effects of Bell's palsy, a common form of facial paralysis that can lead to lasting facial pain, asymmetry, and limited expression. Dr. Yamasaki's insights address modern solutions that improve facial...

Read more

Ensysce Biosciences Completes Significant Milestone, Dosing First Subjects in Breakthrough Therapy PF614-MPAR Trial

November 26, 2024 8:00 AM

Ensysce Biosciences, Inc. (NASDAQ:ENSC) ("Ensysce" or the "Company"), a clinical-stage pharmaceutical company developing innovative solutions for severe pain relief while reducing the potential for opioid abuse and overdose, today announced that it has treated its first group of subjects in the PF614-MPAR-102 study. PF614-MPAR received Breakthrough Therapy designation from the U.S. Food and Drug Administration (FDA) and had its development...

Read more

Unlocking the Mysteries of Consciousness: SIDHE Announces Revolutionary Research Pathways and Transformative Programs

November 26, 2024 8:00 AM

The Syndicated Investigators Delving into Hallucinogens Ethically (SIDHE) Institute and Compassion Center are proud to unveil a groundbreaking slate of initiatives aimed at redefining humanity's relationship with the mind, culture, and the collective unconscious. Rooted in a commitment to safety, ethics, and scientific rigor, SIDHE's work explores uncharted territories at the intersection of ancient traditions, modern science, and experiential...

Read more

Cure Alzheimer’s Fund Marks 20 Years of Progress Toward A Cure

November 26, 2024 6:30 AM

Cure Alzheimer's Fund, a nonprofit dedicated to advancing research with the highest potential to prevent, slow or reverse Alzheimer's disease, has reached a significant milestone-20 years of supporting the field's leading scientists to explore bold ideas and make game-changing discoveries.Since its establishment in 2004, Cure Alzheimer's Fund (CureAlz) has awarded $213 million in funding, distributed via 889 grants led by more than 300...

Read more

AlzeCure Pharma to Present at Redeye Life Science Day on December 3

November 26, 2024 4:20 AM

STOCKHOLM, SWEDEN / ACCESSWIRE / November 26, 2024 / AlzeCure Pharma (STO:ALZCUR)(FRA:AC6) AlzeCure Pharma AB (publ) (FN STO: ALZCUR), a pharmaceutical company that develops candidate drugs for diseases affecting the nervous system, focusing on Alzheimer's disease and pain, today announced that the company is participating at Redeye Life Science Day 2024 on December 3 at 13:00 CET, where CEO Martin Jönsson and CSO Johan Sandin will participate...

Read more

Gold Biotechnology Enhances Visibility and Engagement Through Bioz Partnership

November 26, 2024 4:00 AM

PALO ALTO, CA / ACCESSWIRE / November 26, 2024 / Bioz, Inc., an innovator of AI-powered scientific citation management services, is proud to announce its continued partnership with Gold Biotechnology, a highly respected leader in the field of biological research products. Having collaborated for several years, GoldBio has successfully integrated Bioz's advanced solutions, including Bioz Badges and the Bioz Content Hub, to enhance their...

Read more

PMD Device Solutions Completes Sale of Coala Life Monitor to Inventor Magnus Sörlander

November 26, 2024 2:50 AM

STOCKHOLM, SE / ACCESSWIRE / November 26, 2024 / PMD Device Solutions (FRA:8T0)(STO:PMDS) [Cork, 25th Nov 2024] - PMD Device Solutions (PMDS) today announces the successful completion of the sale of the Coala Life Monitor assets to Magnus Sörlander, the device's inventor and founder. This transaction marks the culmination of a strategic agreement established in May 2024.Under the original agreement, Coala Solutions secured the rights to sell the...

Read more

Women Health Applications Market to Reach USD 17,643.7 Million by 2034 At A 14.6% Of CAGR, driven by Rising Awareness and Preventive Healthcare Focus | Future Market Insights, Inc.

November 26, 2024 2:00 AM

The global Women Health Applications Market is on a significant growth trajectory, with an expected market size of USD 4,515.9 million in 2024, projected to reach USD 17,643.7 million by 2034. This expansion reflects a robust compound annual growth rate (CAGR) of 14.6% from 2024 to 2034. The surge is driven by a variety of factors, including the rising awareness of women's health issues, increasing smartphone adoption, and the demand for...

Read more

Enrollment Completed Five Months Early in the US Clinical Trial Evaluating XVIVOs Heart Preservation Technology

November 25, 2024 6:20 PM

GOTHENBURG, SE / ACCESSWIRE / November 25, 2024 / XVIVO Perfusion AB (STO:XVIVO)(LSE:0RKL)(FRA:3XV) XVIVO's innovative heart technology is currently under investigation in the US clinical trial "PRESERVE: A Prospective, Multi-center, Single-Arm, Open-Label Study of Hearts Transplanted after Non-Ischemic Heart PRESERVation from Extended Donors." This marks the enrollment completion of the Investigational Device Exemption (IDE) trial which was...

Read more

Medicure Reports Financial Results For Quarter Ended September 30, 2024

November 25, 2024 6:00 PM

Medicure Inc. ("Medicure" or the "Company") (TSXV:MPH)(OTC PINK:MCUJF), a company focused on the development and commercialization of pharmaceuticals and healthcare products for patients and prescribers in the United States market, today reported its results from operations for the quarter ended September 30, 2024.Quarter Ended September 30, 2024 Highlights:Recorded total net revenue of $5.2 million during the quarter ended September 30, 2024...

Read more

Justera Health Revises Vesting Schedule of RSU Grant

November 25, 2024 6:00 PM

Justera Health Ltd. (CSE:VTAL)(OTC PINK:SCRSF) ("Justera"or the"Company") announces that the Board of Directors has revised the vesting schedule of the Restricted Share Units ("RSUs") granted on November 8, 2024, to meet the CSE policy 6.1(4). The new vesting schedule is 50% of RSU will be vested four (4) months plus one (1) day from the issuance date, on March 9, 2025, and the remaining 50% of RSU will be vested six (6) months from the date of...

Read more

Juva Life Inc. Updates Shareholders on Court-Appointed Receivership Proceedings

November 25, 2024 1:45 PM

Juva Life Inc. (CSE:JUVA)(OTC PINK:JUVAF)(FRANKFURT:4VV) ("Juva" or the "Company"), a life science company with both pharmaceutical research and development and consumer-facing operations in cannabis production and distribution, announces that, as of November 7, 2024, the Superior Court of California, County of San Joaquin, appointed Kevin Singer of Receivership Specialists as the court-appointed receiver to oversee the Company's assets. This...

Read more

Ankle & Foot Centers of America Highlights Vital Role of Podiatric Care for People with Diabetes

November 25, 2024 12:45 PM

PEACHTREE CITY, GA / ACCESSWIRE / November 25, 2024 / More than 38 million Americans live with diabetes, and one in four will experience diabetes-related foot complications, a leading cause of lower-limb amputation. During National Diabetes Awareness Month, Ankle & Foot Centers of America is emphasizing the importance of comprehensive podiatric care to patients with diabetes, their primary care providers, and their families.Ankle & Foot Centers...

Read more

Wellstack Partners With Hartford HealthCare to Advance Data Integration and Healthcare Analytics

November 25, 2024 10:00 AM

Wellstack, a leader in healthcare data integration and advanced analytics, is proud to announce a strategic partnership with Hartford HealthCare, one of the leading health systems in the Northeast. This collaboration will leverage Wellstack's cutting-edge data platform to support Hartford HealthCare's mission of providing high-quality, patient-centered care through enhanced data-driven decision-making. With over 500 locations, Hartford...

Read more